Learn how to Stop, Cure, and Learn about Swine Flu

 

 

NEWS RELEASE

                                                                                                 Release:

No.

H1N1-15=6

                                                                                                   Date

Mailed:

April

25,

2009

For Immediate Release

Contact: Jackie Lindenbach—208/265-8065; 800/336-9266

 

H1N1-H5N1 Flu Outbreak Implicates Anglo-American “Vaccine Pipeline” Says

Doctor Leonard Horowitz

 

 

Los Angeles, CA— Skyrocketing stock values of Novavax, Inc.,1 precipitated

by dozens of flu deaths in Mexico, implicates a leading Anglo-American

network of genetic engineers in a conspiracy to commit genocide, according

to a Harvard trained expert in emerging diseases, Dr. Leonard Horowitz.

 

Dr. James S. Robertson, England’s leading bioengineer of flu viruses for

the vaccine industry, and avid promoter of U.S. Government funding for

lucrative “biodefense” contracts, along with collaborators at the US

Centers for Disease Control & Prevention (CDC), helped Novavax, Inc., in

Bethesda, Maryland, produce genetically-modified recombinants of the

avian, swine, and Spanish flu viruses, H5N1 and H1N1, nearly identical to

the unprecedented Mexican virus that has now spread to the United States.

The outbreak was precisely timed to promote the company’s new research and

huge vaccine stockpiling contracts, according to Dr. Horowitz.2

 

Scientists at the U.S. Centers for Disease Control (CDC) are implicated

through collaborations and publications involving private contracts with

Novavax, a company that obtains its “biosimulars” through CDC Influenza

Branch director, Ruben O. Donis, and Dr. Rick Bright, previously working

with Donis at the CDC, now Novavax’s Vice President of Global Influenza

Programs.

 

Evidence for the conspiracy to commit deadly duplicity in the vaccine

industry includes the genetic markers on the novel flu virus now spreading

from Mexico to America. The virus is “genetically different from the fully

human H1N1 seasonal influenza virus that has been circulating globally for

the past few years,” according to Reuters and government officials. “The

new flu virus contains DNA typical to avian, swine and human viruses,

including elements from European and Asian swine viruses.”3

 

“That is a description that is pathognomonic, or diagnostic, of a virus

that came from Robertson’s circle of friends,” Dr. Horowitz claims. “No

other group in the world takes H5N1 Asian flu infected chickens, brings

them to Europe, extracts their DNA, combines their proteins with H1N1

viruses from the 1918 Spanish flu isolate, additionally mixes in swine flu

genes from pigs, then ‘reverse engineers’ them to infect humans. The end

product that Reuter’s describes could only end up in Mexico via the United

States from Britain in care of the CDC. Ruben Donis at the CDC had to have

sent them to Novavax, where Rick Bright’s team is now implicated in a

conspiracy to commit genocide—the mass killing of people for profit.”

 

Novavax’s preliminary report in the Journal of Virology, with co-authors

from the CDC in Atlanta, was posted online at the precise time Mexican

officials began reporting deaths from this new strain of flu that is

clearly an unprecedented recombinant of at least three H5N1 and H1N1

strains. Novavax’s Johnny-on-the-spot vaccine was prepared under the CDC’s

“fast track” approval process speciously using these three strains never

known to infect any human in Mexico.

 

Therefore, the statistical probability this virus came from this company

of “experts” is extremely high. Alternatively, anticipated arguments the

virus arrived in Mexico by serendipity, at this precise time in Novavax’s

history, is ridiculously remote.

 

“These doctor’s conflicting corporate, scientific, and financial interests

evidence criminal malfeasance,” said Dr. Leonard Horowitz, an

internationally known humanitarian, award winning consumer health

activist, and author of sixteen books including, Emerging Viruses: AIDS &

Ebola—Nature, Accident or Intentional? (1998, Tetrahedron.org;

1-888-508-4787), His book, and associated scientific publications, have

been cited by numerous authorities as providing compelling evidence the

AIDS virus came from a lab.

 

“The most chilling evidence against the Robertson-Novavax (RN) vaccine

pipeline, besides Robertson being the “gatekeeper” for multi-billion

dollar vaccine stockpiling deals, is Robertson’s influence over the

European Medicines Agency (EMEA)—a quasi-corporate quasi-scientific think

tank serving the European [Economic] Union and drug industry’s special

interests,” Dr. Horowitz said.

 

Dr. Robertson is the Principal Scientist in the Division of Virology at

the National Institute for Biological Standards and Control (NIBSC), akin

to the USFDA in the UK. During a meeting in April, 2006, discussing the

standardization of influenza vaccines on behalf of the World Health

Organization (WHO), it was disclosed, “the NIBSC is involved in the

serological testing of vaccine trials; the preparation and distribution of

influenza viruses to vaccine manufacturers; and the coordination of EU

strain selection[s].” Participants disclosed the EMEA persuades vaccine

makers to bank on pandemics, and “invest in pandemic vaccines with the

introduction of mock up files,” which is their unassuming way of

describing new laboratory engineered influenza viruses also referred to as

“biosimilars.” 4

 

The EMEA waves regulatory fees as an additional incentive to attract more

business for allegedly “biodefense.”4

 

Dr. Robertson, the holder of intellectual property (IP) rights to the

genetic technology used to produce the H5N1 and H1N1 “mock up files” used

to develop Novavax’s vaccine, waived his ownership of the technology

during the company’s research phase with a guaranteed payoff “when the

vaccine is commercialized.” Robertson’s “Material Trade Agreement” (MTA),

covering the transfer of these “biosimilars” to Novavax, is expected to

return millions of dollars when the vaccine is sold to governments

worldwide. 4

 

Novavax’s commercialization and promotions of their vaccine is largely

based on media hype fanning fears and markets for their avian flu, Spanish

flu, and swine flu concoctions. Never before this outbreak has such a

virus, combining the three most feared flu strains, been identified.

 

Mexico’s killer, therefore, evidences a laboratory creation sourcing from

either Novavax’s lab directly, or their partners at the CDC and NIBSC who

maintain multi-million-dollar incentives. The company’s synchronously

timed professional publications, mass media releases, product

representations and commercialization, evidence financial motives to

commit duplicity and mass murder.

 

Days ago, officials at the CDC expressed serious concerns about this novel

flu strain causing a deadly pandemic, not disclosing their obvious

knowledge that the outbreak must have sourced from the materials used in

their cooperative studies with Novavax.5

 

“These doctor’s conflicting corporate, scientific, and financial interests

evidence criminal malfeasance. Killing dozens of people for publicity and

duplicity in public health; to increase marketability of their new

vaccine, is best described as serial homicide to advance genocide—the mass

killing of people for profit,” Dr. Leonard Horowitz explained.

 

The most chilling evidence against Dr. Robertson’s EU research team,

besides him being the gatekeeper and chief promoter for multi-billion

dollar flu vaccine stockpiling deals, and besides his collaborators being

caught red handed here by hard science and common sense, is his stated

position that he believes it is wise to “prime” populations worldwide by

releasing viruses he and his colleagues are creating. This warning comes

from a April 27, 2006, scientific discourse in which Dr. Robertson, and

members of his WHO working group, recommended his “biosimilars” be “used

to prime the population in advance of the pandemic reaching the UK.”

 

In other words, the doctors that hold infectious disease responsibility

for the world have already decided to loose their viruses on unwitting

populations in advance of threatened outbreaks.

 

-End-

 

Note to Journalists: For interviews with Dr. James Robertson,  the NIBSC

lists his contact as: NIBSC, Blanche Lane, South Mimms Potters Bar, Herts

EN6 3QG; Tel: +44 1707 641304; Fax: +44 1707 641050. Dr. Horowitz can be

reached for interviews in southern California, at 949-715-2337. Ruben O.

Donis;s contact information at the Influenza Branch, DVRD, NCID, Centers

for Disease Control and Prevention, is: Mailstop G16, 1600 Clifton Rd,

Atlanta, GA 30333, USA; fax: 404-639-2334; email: rdonis@ cdc.gov. Dr.

Rick Bright can be reached through Novavax.

 

 

 

REFERENCES:

(1) http://uk.reuters.com/article/governmentFilingsNews/idUKN2445216420090424

 

(2) http://ukpmc.ac.uk/articlerender.cgi?artid=1242433

(3) Reuters news release. FACTBOX-New flu strain is a genetic mix. April,

24, 2009. http://www.alertnet.org/thenews/newsdesk/N23371192.htm

(4)

(http://74.125.95.132/search?q=cache:SPJ1B5-EK3sJ:royalsociety.org/downloaddoc.asp%3Fid%3D3521+Summary+of+Oral+Evidence+Dr.+John+Wood&cd=1&hl=en&ct=clnk&gl=us&client=firefox-a)

(5) "CDC Press Briefing Transcripts April 24, 2009". Cdc.gov. 2009-04-24.

http://www.cdc.gov/media/transcripts/2009/t090424.htm. Retrieved on

2009-04-25.

(6) Note: The long term risks of governments purchasing, and people

accepting, vaccines for the flu are unstudied. Yet, the industry and

corporate-controlled governments declare war on biology and discourage

“green” alternatives to vaccinations, such as the most advanced silver

hydrosols (e.g., Oxysilver) in which nano-size anti-microbial silver is

bonded to the oxygen in Water (See: www.Oxysilver.com). There would be no

need for polluting people’s bodies, and the environment, with heavy metals

such as mercury and aluminum, or suffering side effects from antibiotics,

if public health officials promoted the new powerfully protective and

curative silver hydrosols.